1Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease, GOLD executive summary[J]. Am J Respir Crit Care Med,2013,187(4):347-365.
2Agusti A,Sobradillo P, Celli B. Addressing the complexity of chronic obstructive pulmonary disease: from phenotypes and biomarkers to scale-free networks, systems biology, and P4 medicine[J]. Am J Respir Crit Care Med,2011,183(9): 1129- 1137.
3Parr DG. Patient phenotyping and early disease detection in chronic obstructive pulmonary disease[J].Proc Am Thorae Soc, 2011,8(4) : 338-349.
4Han MK, Agusti A, Calverley PM, et al. Chronic obstructive pulmonary disease phenotypes: the future of COPD[J]. Am J Respir Crit Care Med,2010,182(5):598-604.
5Burgel PR, Paillasseur JL, Caillaud D, et al. Clinical COPD phenotypes: a novel approach using principal component and cluster analyses[J]. Eur Respir J,2010,36(3) :531-539.
6Burgel PR, Roche N, Paillasseur JL, et al. Clinical COPD phenotypes identified by cluster analysis., validation with mortality[J]. Eur Respir J, 2012,40(2) : 495-496.
7Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease[J]. N Engl J Med, 2004,350(10) : 1005-1012.
8Martinez FJ, Han MK, Andrei AC, et al. Longitudinal changein the BODE index predicts mortality in severe emphysema [J]. Am J Respir Crit Care Med,2008,178(5) :491-499.
9Ong KC, Earnest A, I.u SJ. A multidimensional grading system( BODE index) as predictor of hospitalization for COPD[J]. Chest,2005,128(6) :3810-3816.
10Cote CG, Celli BR. Pulmonary rehabilitation and the BODE index in COPD[J]. Eur Respir J, 2005,26 (4) : 630-636.
